Indhaha lagu dhibciyo Skulachev: dib u eegista iyo Codsiga

dhibaatada dhabta ah ee nin casriga ah waa hoos u dhac in waxloogu, marmarka qaar ilaa in ay soo afjarto khasaaro. cudurka Eye saameeyaa dadka waayeelka ah, dadka dhallinyarada ah, helay cudurada la midka ah ee caruurta. Sababaha jira dad badan, oo ay ku jiraan hiddo, xaaladaha deegaanka, stress dareemayaasha, dhibaatooyin cudurada viral. Marka tan la eego, ka hor inta cilmi caafimaad hayaan howl muhiim ah - horumarka ee daroogada cusub in ay gacan dib u soo celinta araggooda qaliin la'aan.

mashruuc caafimaad oo baaxad weyn oo ka mid ah jaamacadda caanka ah

Marmar daroogada ka dhibaatooyinka indhaha kala duwan ka muuqan suuqa dawooyinka. Qaar badan oo iyaga ka mid ah run ahaantii waa kuwo wax ku ool ah, laakiin inta badan oo ka mid ah dhibaatooyin halis ah ma daaweeyaan, wax yar oo kaliya dib u horumarka cudurka. Moscow State University - darbiyada mid ka mid ah kuwa ugu fiican u yaqaan ah jaamacadaha ugu faca weyn ee dalka gudihiisa. Lomonosov - oo xidhiidh la leh mashruuca caafimaad ayaa la bilaabay si ay u horumariyaan daawooyinka ah aasaas cusub oo waxtar u leh cudurrada indhaha, oo ay ku jiraan kuwa ay keento isbeddel da'da la xiriira.

On horumarinta daroogada ku qaatay lix sano, ka qaybqaatay mashruuca saddex boqol saynisyahano iyo maskaxda 50 laboratories iyo machadyada. Si kastaba ha ahaatee, daroogada cusub waa qoraaga - saynisyahan caan ah dunida, academician Skulachev. dhibciyo Eye, isticmaalka oo dib u eegista ay sheegayaan in ay awoodaan in ay ilaa xad, si loo soo celiyo aragga, maanta waa sheyga caafimaad certified iyo si firfircoon uga fulin dhex shabakadda rasmiga ah ee farmashiyaha.

tallaabo "daroogada Smart" faray

Shaqada ugu muhiimsan ee daroogada ka yar magaca "Vizomitin" - ilaalinta wilka. Inta badan wilka iyo xanuunka qallalaan, qofka waqti isku mid ah la kulma raaxo iyo dareen ah "ciid indhaha ee", dareen gubasho ah, bilig soo noqnoqda, laakiin gargaarka yimaado dheer. Taa awgeed - casaan iyo indhaha Afguduud.

Gulucdooda Skulachev gebi ahaanba la baabi'iyo calaamadaha "syndrome isha qalalan", ka dibna ay saamayn la faray in ay wax soo saarka ee ilmada dabiiciga ah ee indhaha humidification oo dheeraad ah si looga hortago dhacdo astaamaha cusub. daroogada cusub waa mid la tijaabiyey isaga qudhiisa on qoraaga qudhiisa - academician Skulachev. Waxa uu isticmaalaa dhibcood si joogto ah muddo sannad ah ka hor inta uu helay "cataract". Wakhtigan dhakhtarka logu bukaanka qudbad ka dib markii, laga helay qalliin in aan mar dambe loo baahan yahay. Indhaha lagu dhibciyo horeysay Professor Skulachev u caawisay in ay si weyn u hagaajin gobolka of view.

Research daroogada la filayo

Si aad u taariikhda, cilmi baaris caafimaad ayaa xaqiijiyey saamayn huurka ah ee indhaha lagu dhibciyo "Vizomitin", sidaas isticmaali daroogada this, gaar ahaan sida keratoprotektora. Tusay ayuu isbedel neefo in qanjirka lacrimal, qalajiyo oo ka mid ah dadka Indhihiisa, muddo dheer ka shaqeeya on computer ah, cudurada indhaha la calaamad saameen ah "isha qalalan."

Studies of daroogada sii, ku tilmaamo aragtida aasaasiga ah - awood u leh inay u isticmaalaan dhibic Skulachev ka tirey. Natiijada hadda laga heli karaa waxbarashada clinical soo jeedinaya in mararka qaar ka mid ah caadka in bukaanka ka dib markii codsiga ah ee dhibcood marka hore u daahisay habka daruurtii. Tani waxay u ogolaaneysaa male ah in indhaha lagu dhibciyo Professor Skulachev daweyn karaan caadka qaliin la'aan.

Codsiga xilligan la joogo, waxbarashada

Si kastaba ha ahaatee, malo weli male ah in waxa uu noqon doonaa xaqiiqo ah - arrin waqti. Sidaa darteed, Dhakhaatiirta Indhaha ma saarayso daroogada ka mid ah liiska daroogada lagu daaweyn jiray oo ka mid ah calaamadaha cataract iyo glaucoma, laakiin waxaa lagu talinayaa in aad dalbato dhibic academician Skulachev in therapy isku dhafan, oo ay la socdaan antiglaukomatoznymi kale oo rasmi ah waxay ka dhigan tahay cadaadiska intraocular caadi. nasasho u dhexeeya ku keento ka galay indhaha ka mid ah ama daroogada kale waa in aanay noqon wax ka yar toban daqiiqo, si ay si caadi ah u qaadan saamayn. "Vizomitin" sida caadiga ah ilaa ay maamusho si ay saddex jeer maalintii 1-2 dhibciyo koleyga ee conjunctival. Haddii qalab kale oo la qorsheeyay in inta badan ka yar, halka lagu aaso haray oo kaliya samayn "Vizomitinom".

Isticmaal taxadar ...

Sida daroogo kasta, indhaha lagu dhibciyo Skulachev leeyihiin sababo. First waxaas oo dhan waa da'da 18 sano, si daroogada aan tilmaamay ee daaweynta ee carruurnimada cudurada indhaha. bukaanka ah kuwa ayaa ku soo kordhay dareen in ay ka kooban of daroogada ayaa waxaa sidoo kale lagu qorin "Vizomitin" si looga fogaado dareen diidmo oo xasaasiyadeed. Ha isticmaalin daawada iyo xilliga uurka iyo nuujinta. Marka instilljatsijah double diyaarinta kala duwan daawashada dareenka marka calaamad sida arag isku darsan iyo cawlan, gacanta gaariga waa in laga fogaadaa inta lagu jiro muddada daawaynta.

Hoos u gabowga ah ee jidhkaaga oo dhan ... Khuraafaad ah?

walaxda firfircoon ku jira indhaha lagu dhibciyo "Vizomitin", mar hore at uruuray hooseeyo uu saameyn ku filan oo xoog leh antioxidant. Qoraaga of drug'm gaar ah loo hubiyo in lagu daro soo kabashada ee dhibco lagu shubo indhaha, kuwaas oo kaa caawin hoos gabowga ah ee u shaqeeyo oo dhan. opinion noocan oo kale ah waxay ku salaysan tahay xaqiiqada ah in cuduro gaar ah waxyeello biomolecules ay sabab u tahay kororka of ogsijiin firfircoon. Tani waxay keenaysaa in xaqiiqda ah in unugyada jirka ee lumiyaan difaaca. Sida laga soo xigtay Skulachev ku academician, hordhaca ah ee "Vizomitina" caanuhu horumarinta cudurada sida stroke, Wadnaxanuun maskaxda, arrhythmia wadnaha, iyo sidoo kale dhibaatooyinka kelyaha.

Recovery ka nno caadi ah sida hoos geedi socodka gaboobaya oo si weyn loo hagaajiyo tayada nolosha. Xaqiiqada ah in isha lagu dhibciyo Professor Skulachev gacan ka hortagga cuduro badan, xogta xaqiijiyay daawo rasmi ah kajirin. Tani waxaa laga arki karo malo ah ee daroogada author-sameeysa ah.

guryaha waxtar leh "Vizomitina"

Intaa waxaa dheer, waxaa jira fikrado iyo xaqiiqooyinka jihada waxtar leh jiilka cusub ee dhibco lagu shubo indhaha. Ugu horrayn saamayn antioxidant "Vizomitina" caawisaa unugyada ka dhaawac xagjirka ah oo lacag la'aan ah loo ilaaliyo, hagaajinaysaa geeddi socodka dheefshiidka in unugyada isha. Dhibciyo caawimaad Professor Skulachev si caadi wax soo saarka ee ilmada iyaga u gaar ah, kor loogu qaado xasiloonida ee film jeex, qanjidhada jeex joojin xumaanshaha. Iyada oo dhan of this saameyn ku daweyn adag "Vizomitin" yaraynaysaa bararka isha qaab guduudasho, qallayl, dareenka jirka ajnabi ah. Jira daawooyin si loo baabi'iyo "syndrome isha qalalan" shaqeeyaan on mabda'a ah "ilmada macmal ah", si bukaanka u baahan yahay ku keento ka soo noqnoqda. Sida laga soo xigtay mabda'a "ilmada dabiiciga ah" waxaa uun Skulachev indhaha lagu dhibciyo. Reviews bukaannada lagu daaweeyaa daroogada, soo jeedinaynaa in ay saamayn - dambe, oo ku keento ka soo noqnoqda ayaa loo baahan yahay.

bukaanada waayeelka ah iyo "Vizomitin"

Cayimayo bukaanada waayeelka ah waa in guuro jirkooda, ma dhammaan daawooyinka ku saabsan asalka ah ee soo dhoweynta la kulmi karaan saamaynta kala duwan oo dhinac ah ama dareen diidmo oo xasaasiyadeed. tilmaamaha ee isticmaalka daroogada badan ka akhrisan kartaa, ay yihiin loogu talagalay dadka waayeelka ah ama waxaa lagu talinayaa in la isticmaalo iyada oo ay kormeerayaan caafimaad dhow. Ma jiraan digniino for "Vizomitina". Sida ay ku dhiirigelinayaan in uu, bukaanka ka weyn u dulqaadan dhibcood isha Skulachev. Reviews intooda badan wanaagsan. Dadka si firfircoon ku talinaynaa macnaheedu yahay in midba midka kale, oo badan ayaa dhab ahaan la arkay ee dhaqdhaqaaqa wanaagsan.

dhaqdhaqaaqa wanaagsan ee dadka waayeelka ah

Bukaanjiifka qaar kuwaas oo laga helay "cataract neefo" ayuu ku bilaabay diyaarinta howlgalka of bedelka siku. dhakhaatiirta sida caadiga ah siin ku saabsan laba bilood in hannaanka diyaarinta qaab ku keento. Ka dib markii barashada ku saabsan daroogada cusub, dadka waayeelka ah ayaa loo isticmaalaa indhaha lagu dhibciyo Skulachev. Reviews soo jeedinaya in shantii bilood ee daaweynta ka dib, dhakhtarka la joojiyay qalitaanka, diiwaan hoos u dhac ku size ee cataract.

Waxaa jira qaar ka mid ah bukaanka oo aan tilmaamay ee isbeddel kasta oo ka dib tababar saddex bilood ah ku keento ka "Vizomitinom". Horumarinta ku doodaya in daroogada this leeyahay jilicsan iyo, sida, jilitaanka la'ahay. Sidaa darteed, waa in la isticmaalaa si joogto ah oo wakhti dheer ah. Reviews of qaar ka mid ah bukaanka bukaanka si loo xaqiijiyo opinion this. dhibic badan oo ay horumar weyn oo sanad ama ka badan iyadoo ay sabab u isticmaalka joogtada ah ee dhibcood. Waa sababta oo ah tallaabo aan dagaal badan oo daroogada ah waa gaar ahaan ku haboon dadka da'da ah. Qaar badan oo ka wac qalab this "Skulachev dhibciyo da'da." Reviews bukaanka ka weyn yahay 70 sano waxaa lagu soo gabagabeeyey karaa in dadka si joogto ah u isticmaali dhibcood ee ka hortaga dhibaatooyinka wadnaha.

"Vizomitin" iyo jiilka ka yar

Nasiib darro, dhibaatooyinka aragga kac oo keliya ma aha ee dadka waayeelka ah. Iyo dhalinyarada sii kordheysa aragto at xadgudubyo halis ah ee shaqada la daawado. bukaan badan ayaa u jeestay dhibic Skulachev ay fiiro. Reviews dadka dhalinyarada ah ayaa muujinaya wanaagsan, iyo waxtarka daawada.

Bukaanjiifka qaar sheegaan dareen oo dab ka ololayo yar indhaha ee bilowga ah ee koorsada, taasoo dhaceyso in dhowr toddobaad. ku dhiirigelinayaan in uu tilmaamay in tani ma aha cudurada ah oo la xidhiidha muujin ka timid xaalad jir ah xuub-axaleedka sida. ra'yi-celin wanaagsan waxay hellayaan kuwa dadka dhalinyarada ah ee lagu khasbay inay shaqeeyaan saacado dheer at kombiyuutarka. Kuwa kuwa aan rumaysan in oggolyahay ee daroogada, si kastaba ha ahaatee, ayaa tilmaamay in ka dib markii dhowr toddobaad gebi ahaanba la joojiyey xanuun indhaha, tegey oo cas. Xaaladaha sidoo kale loo hagaajiyo aragtida bukaanka qaba go'idda, inkastoo dad badan oo qirtay in dhakhtarku ma aha in si dhaqso ah, sidii la arkay ayaa noqday kuwa aad u fiican. Secure si rasmi ah horumarinta xaaladaha kuwaas oo aan la bixiyey, sidoo kale si loo ogaado gobolka dhabta ah ee view.

opinion Dhakhaatiirta Indhaha ku saabsan daroogada

Sanadihii la soo dhaafay, tiro sii kordhaysa oo dhakhaatiirta ku takhasusay indhaha, talinaynaa in Vizomitin bukaanada ay ' ". Inta badan ku dhaqanka Dhakhaatiirta Indhaha, wuxuu bilaabay inuu la kulmo ka dib markii uu si rasmi ah u saaray liiska daroogada lagu daaweyn jiray cataract iyo gulucdooda glaucoma professor da'da la xiriira Skulachev. Reviews dhakhtarrada ayaa muujinaya in xaaladda bukaannada ay ayaa si weyn u soo hagaagtay iyadoo ay sabab ka mid ah kuwan dhibcood ku keento. Dhakhaatiirta Indhaha ku doodaya in daawo caadka da'da la xiriira dhibciyo ma aha suurto gal ah, si kastaba ha ahaatee, ay ku buuxin karaan iyo in la wanaajiyo xaaladda aad u dhabta ah.

Compliance leh xeerarka kaydinta - fure u ah waxtarka daawada

Waxaa jira dib u eegista negative yar, falanqaynta taas waxa ay u muuqataa in bukaanka si fiican u dhawray dhibcood isha Skulachev. kuwaas oo u eegid ku saabsan la'aanta ah ee waxtarka of daroogada, laakiin ku dhiirigelinayaan in uu ku tilmaamay in ay baadi bukaanka: daroogada waxa lagu kaydiyaa qaboojiyaha. Waxaa lagu kaydin karaa heerkulka qolka muddo ka badan laba maalmood, laakiin waa in aan ka fogaano qorraxdu si toos ah iyo xitaa iftiinka uga laambadihii. Nasiib darro, ma aha had iyo jeer suurto gal ah in ay noqon gaar ah, iyo in si sax ah loo kaydiyaa at isha farmashiyaha lagu dhibciyo Skulachev. Reviews ku saabsan waxtardarradoodu ee daroogada markii xuquuqda kaydiyaa bukaannada soo jeedin xadgudubyada ay geystaan shaqaalaha farmasiiga ah ee farmashiyaha keeni kara daawooyin tayo liita.